STOCK TITAN

If You Invested in Molecular Data Inc (MKD)

Looking for the current price? See the MKD quote & overview
$1,000 invested 1 Year Ago
N/A
Trading since 2019-12-30
$1,000 invested 5 Years Ago
$73
-92.7% price return -95.4% CAGR
-92.7% with dividends reinvested
Bought on Oct 29, 2021 at $5.64 split-adjusted

What $1,000 or $10,000 in MKD Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Dec 30, 2019
$1,000 — $73 -93% — $5 -99%
$10,000 — $727 -93% — $50 -99%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2022-09-06. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for MKD

$1,000 Investment Over Time

MKD vs S&P 500

Year-by-Year Returns

MKD annual performance
Year Start Price End Price Annual Return Cumulative
2019 $81.90 $71.70 -12.5% -12.5%
2020 $71.70 $12.60 -82.4% -84.6%
2021 $12.60 $3.27 -74.0% -96.0%
2022 $3.27 $0.41 -87.5% -99.5%

About Molecular Data Inc

Current Price
$0.41
View full MKD overview

Frequently Asked Questions

Molecular Data Inc investment returns

How much would $1,000 invested in Molecular Data Inc be worth today?

If you invested $1,000 in Molecular Data Inc (MKD) 5 years ago on 2021-10-29, your investment would be worth $73 as of 2022-09-06, a -92.7% price return without dividends, growing at a compounded rate of -95.4% per year (CAGR).

Has Molecular Data Inc outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare MKD performance over available time periods.

What is Molecular Data Inc's average annual return?

The compound annual growth rate (CAGR) of MKD’s share price over the past 5 years is -95.4%, without dividends. Individual years vary a great deal, and MKD’s best recent full year was 2021 (-74.0%) while the worst was 2020 (-82.4%).

For informational and educational purposes only, not investment advice.